Senate Committee on Appropriations Approves FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) Appropriations Bill & Accompanying Report

The Senate Committee on Appropriations approved its FY 2026 Labor, Health and Human Services, Education, and Related Agencies (Labor HHS) appropriations bill, accompanying report, and amendments on July 31, 2025. While most U.S. global health funding is provided to the State Department through a separate appropriations bill, the Labor HHS appropriations bill includes funding for…More

Read More

Listen: As Kids Head Back to School, Parents Sort Out Confusion Over Vaccine Access

LISTEN: Measles. Chickenpox. Meningitis. Many vaccines can run more than $100 a dose out-of-pocket. Jackie Fortiér tells WAMU’s “Health Hub” how Trump administration changes to the federal vaccine guidelines could make some routine shots too expensive for families. Health and Human Services Secretary Robert F. Kennedy Jr., a longtime anti-vaccine activist, replaced the members of…

Read More

RSVP: A Live Election Episode of KFF Health News’ ‘What the Health?’ Podcast

‘What the Health?’ are the Health Implications of the Election? The Event: A live taping of ‘What the Health?’, KFF Health News’ premier policy news podcast Moderator Julie Rovner, chief Washington correspondent, KFF Health News Panelists Ashley Kirzinger, director of survey methodology and associate director of the Public Opinion and Survey Research Program, KFF Cynthia…More

Read More

Can the NIH replace all private sector clinical R&D?

A paper by Proudman et al. (2024) finds that doing so would be extremely expensive. Including all preclinical, clinical and post-approval R&D activities, total annual costs to maintain the average lifecycle level of 49.4 approved drugs across all disease areas during the 2018–22 period was estimated to be $139.6 billion. Including only pre-launch costs, total…

Read More